BARCLAYS PLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,451
-27.2%
114,041
-19.5%
0.00%0.0%
Q2 2023$1,993
+2.7%
141,595
+12.8%
0.00%0.0%
Q1 2023$1,940
-29.7%
125,569
-25.4%
0.00%0.0%
Q4 2022$2,760
-99.9%
168,339
+7.8%
0.00%
-66.7%
Q3 2022$2,890,000
+421.7%
156,230
+270.7%
0.00%
Q2 2022$554,000
-66.9%
42,148
-76.6%
0.00%
-100.0%
Q1 2022$1,672,000
-39.0%
180,374
-35.7%
0.00%0.0%
Q4 2021$2,742,000
+26.9%
280,566
+341.3%
0.00%0.0%
Q3 2021$2,161,000
+94.3%
63,579
+109.2%
0.00%0.0%
Q2 2021$1,112,000
-72.5%
30,393
-66.4%
0.00%
-50.0%
Q1 2021$4,051,000
+33.1%
90,367
+69.5%
0.00%0.0%
Q4 2020$3,044,000
+186.1%
53,310
+157.0%
0.00%
+100.0%
Q3 2020$1,064,000
-58.4%
20,747
-51.5%
0.00%
-50.0%
Q2 2020$2,556,000
+7.2%
42,800
-26.1%
0.00%0.0%
Q1 2020$2,385,000
+22.0%
57,920
+84.4%
0.00%
+100.0%
Q4 2019$1,955,000
+71.8%
31,408
-6.4%
0.00%0.0%
Q3 2019$1,138,000
+426.9%
33,548
+250.2%
0.00%
Q2 2019$216,000
-7.7%
9,581
-4.8%
0.00%
Q1 2019$234,000
-19.9%
10,063
-27.6%
0.00%
Q4 2018$292,000
+55.3%
13,908
+187.7%
0.00%
Q3 2018$188,000
+327.3%
4,835
+328.3%
0.00%
Q2 2018$44,000
-48.8%
1,129
-73.4%
0.00%
Q1 2018$86,000
+186.7%
4,245
+224.5%
0.00%
Q4 2017$30,000
-93.7%
1,308
-94.8%
0.00%
Q3 2017$475,00025,0000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$11,213,0005.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,580,456$51,731,0001.16%
ARMISTICE CAPITAL, LLC 5,836,000$54,100,0001.05%
Pinz Capital Management, LP 165,835$1,537,0000.96%
Sunesis Advisors, LLC 96,299$893,0000.52%
Redmile Group, LLC 664,817$6,163,0000.19%
PDT Partners, LLC 222,343$2,061,0000.18%
Bayesian Capital Management, LP 41,900$388,0000.06%
Laurion Capital Management LP 459,290$4,258,0000.05%
Hennion & Walsh Asset Management, Inc. 101,643$942,0000.05%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders